| 2024-03-19 | Sale | Stoke Therapeutics, Inc. STOK | CFO | 4,116 0.0097% | $6.10 | $25,102 | +125.3% | |
| 2021-02-23 | Sale | Stoke Therapeutics, Inc. STOK | CFO | 5,000 0.0135% | $58.60 | $292,992 | -54.39% | |
| 2021-02-22 | Sale | Stoke Therapeutics, Inc. STOK | CFO | 25,000 0.0688% | $58.92 | $1.47M | -53.67% | |
| 2020-11-04 | Sale | Stoke Therapeutics, Inc. STOK | CFO | 33,268 0.1021% | $40.80 | $1.36M | -9.65% | |
| 2020-11-03 | Sale | Stoke Therapeutics, Inc. STOK | CFO | 1,732 0.0052% | $39.84 | $68,998 | -8.8% | |
| 2020-11-02 | Sale | Stoke Therapeutics, Inc. STOK | CFO | 35,000 0.1035% | $37.25 | $1.3M | -4.52% | |
| 2017-02-17 | Aldeyra Therapeutics, Inc. ALDX | Chief Financial Officer | 6,666 0.0426% | $4.50 | $29,997 | +0.98% |